Treatment of asymptomatic rectal Chlamydia trachomatis: Is single-dose azithromycin effective?

International Journal of STD and AIDS

Volumn 20, Issue 1, 2009, Pages 16-18

  Steedman, N M ^a   McMillan, A ^b  

^a Countess of Chester NHS Foundation Trust ^*  (United Kingdom)

^b Lauriston Building ^*  (United Kingdom)

Author keywords

Azithromycin; Chlamydia trachomatis; Rectal; Treatment

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN;

ADOLESCENT; ADULT; AGED; ANORECTAL DISEASE; ARTICLE; BACTERIUM CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM; RECTUM DISEASE; RETROSPECTIVE STUDY; SEXUAL HEALTH; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; SYMPTOM;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GREAT BRITAIN; HUMANS; MALE; RECTAL DISEASES; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58249097424     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008211     Document Type: Article

References (8)

1. Manavi K, McMillan A, Young H. The prevalence of rectal chlamydial infection amongst men having sex with men attending the genitourinary medicine clinic in Edinburgh. Int J STD AIDS 2004;15:162-4
2. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to HIV transmission. Sex Transm Infect 1999;75:3-17
3. Kiviat NB, Critchlow CW, Hawes SE, et al. Determinants of human immunodeficiency virus DNA and RNA shedding in the anal-rectal canal of homosexual men. J Infect Dis 1998;177:571-8
4. BASHH UK National Guideline for the Management of Genital Tract Infection with Chlamydia trachomatis. 2006. See http://www.bashh.org/ documents/61/61.pdf (Last accessed 17 November 2008)
5. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002;29:497-502
6. Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P, Quinn TC. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998;177:417-24
7. Ossewaarde JM, Plantema FHF, Reiffe M, Nawrocki RP, de Vries A, van Loon AM. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis 1992;11:693-7
8. Hillis SD, Coles F, Bruce DO, et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings. Sexually Transmitted Diseases 1998;25:5-11